Your browser doesn't support javascript.
loading
Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part I. Development, Diagnosis and Differential Diagnosis.
Alidjanov, Jakhongir F; Naber, Kurt G; Abdufattaev, Ulugbek A; Pilatz, Adrian; Wagenlehner, Florian M E.
Afiliação
  • Alidjanov JF; The Republican Specialized Center of Urology, 100109 Tashkent, Uzbekistan. jakhonghir@hotmail.com.
  • Naber KG; Clinic of Urology, Paediatric Urology and Andrology, Justus-Liebig-University, 35392 Giessen, Germany. jakhonghir@hotmail.com.
  • Abdufattaev UA; Department of Urology, School of Medicine, Technical University of Munich, D-80333 Munich, Germany. kurt@nabers.de.
  • Pilatz A; The Republican Specialized Center of Urology, 100109 Tashkent, Uzbekistan. abdufattaev@gmail.com.
  • Wagenlehner FME; Clinic of Urology, Paediatric Urology and Andrology, Justus-Liebig-University, 35392 Giessen, Germany. pilatz@t-online.de.
Antibiotics (Basel) ; 7(1)2018 Jan 15.
Article em En | MEDLINE | ID: mdl-30720775
ABSTRACT
This study aimed to reevaluate the Acute Cystitis Symptom Score (ACSS). The ACSS is a simple and standardized self-reporting questionnaire for the diagnosis of acute uncomplicated cystitis (AC) assessing typical and differential symptoms, quality of life, and possible changes after therapy in female patients with AC. This paper includes literature research, development and evaluation of the ACSS, an 18-item self-reporting questionnaire including (a) six questions about "typical" symptoms of AC, (b) four questions regarding differential diagnoses, (c) three questions on quality of life, and (d) five questions on additional conditions that may affect therapy. The ACSS was evaluated in 228 women (mean age 31.49 ± 11.71 years) in the Russian and Uzbek languages. Measurements of reliability, validity, predictive ability, and responsiveness were performed. Cronbach's alpha for ACSS was 0.89, split-half reliability was 0.76 and 0.79 for first and second halves, and the correlation between them was 0.87. Mann-Whitney U test revealed a significant difference in scores of the "typical" symptoms between patients and controls (10.50 vs. 2.07, p < 0.001). The optimal threshold score was 6 points, with a 94% sensitivity and 90% specificity to predict AC. The "typical" symptom score decreased significantly when comparing before and after therapy (10.4 and 2.5, p < 0.001). The reevaluated Russian and Uzbek ACSS are accurate enough and can be recommended for clinical studies and practice for initial diagnosis and monitoring the process of the treatment of AC in women. Evaluation in German, UK English, and Hungarian languages was also performed and in other languages evaluation of the ACSS is in progress.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article